The testicular-hypothalamicpituitary axis regulates male reproductive system functions. Understanding these regulatory mechanisms is important for assessing the reproductive effects of environmental and pharmaceutical androgenic and antiandrogenic compounds. A mathematical model for the dynamics of androgenic synthesis, transport, metabolism, and regulation of the adult rodent ventral prostate was developed on the basis of a model by Barton and Anderson (1997). The model describes the systemic and local kinetics of testosterone (T), 5␣-dihydrotestosterone (DHT), and luteinizing hormone (LH), with metabolism of T to DHT by 5␣-reductase in liver and prostate. Also included are feedback loops for the positive regulation of T synthesis by LH and negative regulation of LH by T and DHT. The model simulates maintenance of the prostate as a function of hormone concentrations and androgen receptor (AR)-mediated signal transduction. The regulatory processes involved in prostate size and function include cell proliferation, apoptosis, fluid production, and 5␣-reductase activity. Each process is controlled through the occupancy of a representative gene by androgen-AR dimers. The model simulates prostate dynamics for intact, castrated, and intravenous T-injected rats. After calibration, the model accurately captures the castration-induced regression of the prostate compared with experimental data that show that the prostate regresses to ϳ17 and 5% of its intact weight at 14 and 30 days postcastration, respectively. The model also accurately predicts serum T and AR levels following castration compared with data. This model provides a framework for quantifying the kinetics and effects of environmental and pharmaceutical endocrine active compounds on the prostate. rodent ventral prostate; androgen receptor; testosterone; 5␣-dihydrotestosterone; testicular-hypothalamic-pituitary axis THE HYPOTHALAMUS, PITUITARY, AND TESTES produce endocrine hormones responsible for regulation of the prostate and other male sexual functions (12, 46). Exogenous endocrine active compounds can disrupt these processes. Some pesticides (e.g., vinclozolin and linuron) are known to have antiandrogenic activity (19,20). Toxic effects of antiandrogens in male rodents range from developmental effects such as reproductive malformations, retained nipples, and undescended testes to pubertal effects such as delayed puberty and reduced weights of prostate and other reproductive organs. In the pharmaceutical setting, therapeutic drugs such as finasteride, dutasteride, bicalutamide, and flutamide are used to treat benign prostatic hyperplasia and/or prostate cancer by inhibiting androgendependent growth processes.The mechanisms of action of antiandrogens are generally of two forms. The first is the androgen antagonist, which binds to the androgen receptor (AR) but does not stimulate DNA transcription, such as the pharmaceutical compounds flutamide and bicalutamide or the environmental compound vinclozolin. The second is the 5␣-reductase inhibitor, which blocks th...